- Home
- ETON vs ITRG Comparison
ETON vs ITRG Comparison
Compare ETON & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- ITRG
- Stock Information
- Founded
- ETON 2017
- ITRG 1997
- Country
- ETON United States
- ITRG Canada
- Employees
- ETON N/A
- ITRG N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- ITRG Precious Metals
- Sector
- ETON Health Care
- ITRG Basic Materials
- Exchange
- ETON Nasdaq
- ITRG Nasdaq
- Market Cap
- ETON 199.5M
- ITRG 84.2M
- IPO Year
- ETON 2018
- ITRG N/A
- Fundamental
- Price
- ETON $8.82
- ITRG $1.20
- Analyst Decision
- ETON Strong Buy
- ITRG Strong Buy
- Analyst Count
- ETON 3
- ITRG 1
- Target Price
- ETON $12.00
- ITRG $3.75
- AVG Volume (30 Days)
- ETON 214.1K
- ITRG 259.4K
- Earning Date
- ETON 11-11-2024
- ITRG 11-12-2024
- Dividend Yield
- ETON N/A
- ITRG N/A
- EPS Growth
- ETON N/A
- ITRG N/A
- EPS
- ETON N/A
- ITRG N/A
- Revenue
- ETON $31,381,000.00
- ITRG N/A
- Revenue This Year
- ETON $19.61
- ITRG N/A
- Revenue Next Year
- ETON $35.39
- ITRG $360.53
- P/E Ratio
- ETON N/A
- ITRG N/A
- Revenue Growth
- ETON 8.14
- ITRG N/A
- 52 Week Low
- ETON $3.03
- ITRG $0.64
- 52 Week High
- ETON $8.66
- ITRG $1.28
- Technical
- Relative Strength Index (RSI)
- ETON 76.07
- ITRG 66.49
- Support Level
- ETON $7.58
- ITRG $0.95
- Resistance Level
- ETON $8.66
- ITRG $1.28
- Average True Range (ATR)
- ETON 0.42
- ITRG 0.07
- MACD
- ETON -0.07
- ITRG 0.01
- Stochastic Oscillator
- ETON 91.49
- ITRG 77.27
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of highly prospective early-stage exploration projects in Idaho, Nevada, and Arizona.